Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Trientine Hydrochloride
Therapeutic Area : Genetic Disease
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 27, 2015
Lead Product(s) : Trientine Hydrochloride
Therapeutic Area : Genetic Disease
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Trientine Hydrochloride
Therapeutic Area : Genetic Disease
Study Phase : Phase I
Sponsor : Aptiv Solutions
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 10, 2013
Lead Product(s) : Trientine Hydrochloride
Therapeutic Area : Genetic Disease
Highest Development Status : Phase I
Sponsor : Aptiv Solutions
Deal Size : Inapplicable
Deal Type : Inapplicable